🔥 Friday 17 July 2026 Fri, 17 July 2026

Aguia Resources has reported exceptional multi-ounce gold grades from underground channel sampling at its Santa Barbara Gold Project in Colombia, alongside ongoing shaft construction and mine development.

Starpharma Holdings is raising approximately $32 million through a fully underwritten 1-for-7.5 renounceable entitlement offer priced at $0.57 per share, discounting the stock by 25%. Proceeds will fund the DEP HER2-Lu Phase 1 trial and expand its dendrimer-based oncology pipeline.

Resolution Minerals has earned FAST-41 transparency status for its Golden Gate Project in Idaho, marking its second such designation and positioning the company as a key player in U.S. critical minerals supply chain development.

Tartana Minerals has locked in a $5.18 million placement with Chinese mining giant Xingye Gold at a striking 165% premium to its last traded price, setting the stage for accelerated exploration and a new strategic partnership.

Neurizon Therapeutics has completed enrolment for Regimen I of its HEALEY ALS Platform Trial in under five months, speeding up topline data release to late Q2 2027 and materially de-risking its lead clinical program.

Cyprium Metals is on the cusp of restarting copper cathode production at its Nifty Copper Complex, targeting the September quarter 2026 for first output as key infrastructure nears completion. Meanwhile, the company advances growth strategies including a potential SXEW plant capacity expansion and exploration of oxide ores.

Critical Resources' 2026 field program at Mavis Lake identifies highly fractionated lithium-caesium-tantalum pegmatites in newly acquired northern claims, sharpening drill targets and bolstering its multi-deposit lithium district ambitions.

Dimerix has acquired DMX-652, a Phase 2-ready oral drug candidate targeting acute kidney injury, expanding its renal disease portfolio. The acquisition includes patent rights, an FDA-approved trial protocol, and funding to initiate clinical development.

LTR Pharma has formalised its US commercialisation strategy by signing a definitive agreement with telehealth leader Shed, targeting at least 150,000 ROXUS units in the first year through digital men’s health platforms.

Beacon Minerals delivered steady gold output of 5,241 ounces in Q2 2026 at its Jaurdi Gold Project, alongside a fully franked cash dividend and a significant in-specie distribution of Forrestania Resources shares to shareholders.

Pursuit Minerals has reported promising early results from its DDH-3 drillhole at the Mito tenement, recovering highly saline brines consistent with its geological model and supporting the potential for significant lithium resources.

Nordic Resources (ASX:NNL) has reported new drill results extending gold-copper mineralisation 30-100m beyond the current resource boundary at its Kopsa project in Finland, with geophysical data suggesting depth continuity. The company plans further drilling and a resource update in 2026.

Alcoa Corporation delivered a record quarterly revenue of $4 billion in Q2 2026, boosted by strong aluminium prices and operational restarts, while advancing a major acquisition of South32’s upstream assets.

Regis Resources has boosted its FY27 gold production guidance to 360-400koz, driven by higher output at Duketon and sustained growth capital investment.

Perseus Mining is ramping up underground production and expanding its resource base at the Yaouré Gold Mine in Côte d’Ivoire, supported by a $34 million FY27 drilling program aimed at extending mine life and boosting mineral resources.